Copyright © 1997 by the European Society of Cardiology.
© 1997 The European Society of Cardiology
Survey on heart failure in Italian hospital cardiology units
Results of the SEOSI study
The SEOSI Investigatorsaccepted 14 February 1997.
Correspondence: L. Tavazzi, Centro Studi ANMCO, Via La Marmora 36-50121 Florence, Italy
Abstract
Three hundred and fifty nine cardiology units participated in a study (SEOSI) coordinated by the Association of Italian Hospital Cardiologists (ANMCO). The aim of the study was to: (1) evaluate how many patients with suspected or known heart failure consecutively approach a hospital cardiology unit; (2) assess their clinical characteristics; (3) define the diagnostic-therapeutic processes set in motion by cardiologists; (4) evaluate the social and emotional impact of the disease on the patient.
In 12 days, 3921 patients were enrolled. Mean age was 67±12 years (median 69); 49% of the patients were in NYHA class III–IV; atrial fibrillation was present in 27%; 35% of the cases were scheduled for hospital admission. Ischaemic heart disease was the primary cause of heart failure (42%); arterial hypertension accounted for 20%, idiopathic dilated cardiomyopathy for 15% and cardiac valve disease for 15%. A chest X-ray, ECG and echocardiogram were performed in 70–80% of cases; ambulatory ECG in 36% and exercise testing in 11%. ACE inhibitors were administered to 63·5% calcium antagonists to 19% and beta-blockers to 5·5%. No significant differences in drug prescription were noted in relation to NYHA classification. Multidrug use was common (3·6±1·6). Main advice was: salt restriction (47%) and rest (44%); physical activity and a formal exercise programme were prescribed to 10% and 5% of patients, respectively. Most patients were addressed to hospital follow-up.
Thus, heart failure represents a heavy burden for hospital cardiology units. It can be estimated that about 190 000 patients with heart failure seek care at hospital cardiology units each year and about 65 000 are admitted as inpatients. Cardiologists are reasonably well oriented regarding both examinations required and the prescribing of drugs. Beta-blockers and physical exercise are prescribed very cautiously. The format of the present trial, characterized by brevity, simplicity and low cost, could be used as a tool to gain periodical information on several aspects of national health systems and physician behaviour.
Key Words: Heart failure • heart failure units • epidemiology • cardiology hospital care unit • decision making
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. A. Patel and M. A. Fotis Comparison of treatment of patients with congestive heart failure by cardiologists versus noncardiologists Am. J. Health Syst. Pharm., January 15, 2005; 62(2): 168 - 172. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. P. Maggioni, I. Anand, S. O. Gottlieb, R. Latini, G. Tognoni, J. N. Cohn, and the Val-HeFT Investigators Effects of valsartan on morbidity and mortality in patients with heart failure not receiving angiotensin-converting enzyme inhibitors J. Am. Coll. Cardiol., October 16, 2002; 40(8): 1414 - 1421. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Capomolla, O. Febo, M. Ceresa, A. Caporotondi, G. Guazzotti, M. T. La Rovere, M. Ferrari, F. Lenta, S. Baldin, C. Vaccarini, et al. Cost/utility ratio in chronic heart failure: comparison between heart failure management program delivered by day-hospital and usual care J. Am. Coll. Cardiol., October 2, 2002; 40(7): 1259 - 1266. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Varela-Roman, J R Gonzalez-Juanatey, P Basante, R Trillo, J Garcia-Seara, J L Martinez-Sande, and F Gude Clinical characteristics and prognosis of hospitalised inpatients with heart failure and preserved or reduced left ventricular ejection fraction Heart, September 1, 2002; 88(3): 249 - 254. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Grigioni, V. Carinci, L. Favero, L. B. Reggiani, G. Magnani, L. Potena, A. Barbieri, C. Magelli, A. Branzi, and B. Magnani Hospitalization for congestive heart failure: is it still a cardiology business? Eur J Heart Fail, January 1, 2002; 4(1): 99 - 104. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Bellotti, L.P. Badano, N. Acquarone, R. Griffo, G. Lo Pinto, A.P. Maggioni, C. Mattiauda, G. Menardo, and P. Mombelloni Specialty-related differences in the epidemiology, clinical profile, management and outcome of patients hospitalized for heart failure. The OSCUR study Eur. Heart J., April 1, 2001; 22(7): 596 - 604. [Abstract] [PDF]
|
|
|
|
|
|
M. Senni and A. Gavazzi How patients with heart failure are managed in Italy Eur J Heart Fail, March 1, 2001; 3(2): 257 - 260. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Tavazzi Towards a more precise definition of heart failure aetiology Eur. Heart J., February 1, 2001; 22(3): 192 - 195. [PDF]
|
|
|
|
|
|
K.F Fox, M.R Cowie, D.A Wood, A.J.S Coats, J.S.R Gibbs, S.R Underwood, R.M Turner, P.A Poole-Wilson, S.W Davies, and G.C Sutton Coronary artery disease as the cause of incident heart failure in the population Eur. Heart J., February 1, 2001; 22(3): 228 - 236. [Abstract] [PDF]
|
|
|
|
|
|
A Cohen-Solal, M Desnos, F Delahaye, J.P Emeriau, and G Hanania A national survey of heart failure in French hospitals Eur. Heart J., May 1, 2000; 21(9): 763 - 769. [Abstract] [PDF]
|
|
|
|
|
|
M. C. Albanese, M. Plewka, D. Gregori, C. Fresco, G. Avon, D. Caliandro, L. Grassi, P. Rossi, P. Udina, A. Bulfoni, et al. Use of medical resources and quality of life of patients with chronic heart failure: a prospective survey in a large Italian community hospital Eur J Heart Fail, December 17, 1999; 1(4): 411 - 417. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Comini, T. Bachetti, L. Agnoletti, G. Gaia, S. Curello, B. Milanesi, M. Volterrani, G. Parrinello, C. Ceconi, A. Giordano, et al. Induction of functional inducible nitric oxide synthase in monocytes of patients with congestive heart failure. Link with tumour necrosis factor-{alpha} Eur. Heart J., October 2, 1999; 20(20): 1503 - 1513. [Abstract] [PDF]
|
|
|
|
|
|
L. Ryden ACE inhibitors or AT1receptor blockers in heart failure? Eur. Heart J., September 2, 1999; 20(18): 1287 - 1289. [PDF]
|
|
|
|
|
|
B.A. Bart, G. Ertl, P. Held, J. Kuch, A.P. Maggioni, J. McMurray, E.L. Michelson, J.L. Rouleau, L. Warner Stevenson, K. Swedberg, et al. Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) Registry Eur. Heart J., August 2, 1999; 20(16): 1182 - 1190. [Abstract] [PDF]
|
|
|
|
|
|
A P MAGGIONI and L TAVAZZI Introducing new treatments in clinical practice: the Italian approach to beta blockers in heart failure Heart, May 1, 1999; 81(5): 453 - 454. [Full Text]
|
|